chrX-151955051-G-A
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4BS2
The NM_004961.4(GABRE):c.1171C>T(p.Arg391Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000276 in 1,088,772 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 2 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_004961.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GABRE | NM_004961.4 | c.1171C>T | p.Arg391Cys | missense_variant | 9/9 | ENST00000370328.4 | NP_004952.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GABRE | ENST00000370328.4 | c.1171C>T | p.Arg391Cys | missense_variant | 9/9 | 1 | NM_004961.4 | ENSP00000359353 | P1 | |
GABRE | ENST00000486255.1 | n.4250C>T | non_coding_transcript_exon_variant | 3/3 | 1 | |||||
GABRE | ENST00000483564.5 | n.821C>T | non_coding_transcript_exon_variant | 4/4 | 3 | |||||
GABRE | ENST00000495862.1 | downstream_gene_variant | 3 |
Frequencies
GnomAD3 genomes Cov.: 23
GnomAD3 exomes AF: 0.0000122 AC: 2AN: 163320Hom.: 0 AF XY: 0.0000197 AC XY: 1AN XY: 50794
GnomAD4 exome AF: 0.00000276 AC: 3AN: 1088772Hom.: 0 Cov.: 32 AF XY: 0.00000563 AC XY: 2AN XY: 355402
GnomAD4 genome Cov.: 23
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 16, 2023 | The c.1171C>T (p.R391C) alteration is located in exon 9 (coding exon 9) of the GABRE gene. This alteration results from a C to T substitution at nucleotide position 1171, causing the arginine (R) at amino acid position 391 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at